DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹50 Cr | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr | ₹1,987 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹-1,045 Cr |
| Mar2022 | ₹-816 Cr |
| Mar2021 | ₹1,987 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹50 Cr | -74.09 | |
| Mar2024 | ₹193 Cr | Positive | |
| Mar2023 | ₹-1,045 Cr | Negative | |
| Mar2022 | ₹-816 Cr | Negative | |
| Mar2021 | ₹1,987 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹155,503.4 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
| MANKIND PHARMA | ₹82,460.4 Cr | -1.1% | -11.1% | -16.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -2.6% |
-8.7% |
1.2% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses